Urinary Sodium and Potassium, and Aldosterone Secretion before and after Guanethidine Treatment, and Six Months after Surgical Removal of the Tumor (the Stippled Areas Represent the Normal Ranges).

Recent studies have highlighted the challenges of managing potassium levels in patients with CKD, particularly those receiving renin-angiotensin-aldosterone system inhibitors (RAASi), which are ...

This process is influenced by hormones such as aldosterone, which increases potassium excretion, and is also affected by the body’s acid-base balance. Finally, any excess potassium that is not ...

Potassium and renal function must be routinely assessed to minimize the risk of life-threatening hyperkalemia. This review discusses the role of aldosterone antagonists in the treatment of heart ...

In a patient with Bartter's syndrome (increased plasma renin, juxtaglomerular-cell hyperplasia, hyperaldosteronism and hypokalemia, but no hypertension), aldosterone excretion and secretion were ...

New York, NY) is an aldosterone blocker that works by binding at the mineralocorticoid receptor. It has some similarities to the potassium-sparing diuretic spironolactone, but rarely causes ...

Nursing mothers. Avoid concomitant potassium-sparing diuretics. Monitor for hyperkalemia with drugs that inhibit the renin-angiotensin-aldosterone sytem (eg, ACE inhibitors, ARBs, spironolactone ...